medigraphic.com
SPANISH

Revista Mexicana de Neurociencia

Academia Mexicana de Neurología, A.C.
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2016, Number 4

<< Back Next >>

Rev Mex Neuroci 2016; 17 (4)

Neurological manifestations of Castleman disease: A case report

Belli MHR, Cauich EE, Cih OGA, Ruiz GJ, Jiménez BMV
Full text How to cite this article

Language: Spanish
References: 11
Page: 116-124
PDF size: 643.45 Kb.


Key words:

Castleman, disorder lymphoproliferative, hyaline-vascular, leptomenignitis.

ABSTRACT

Introduction: Castleman disease (CD) is a rare entity characterized by non-tumoral proliferation of lymphatic tissue, that occurs with equal frequency in both sexes and at any age, however, it prevails between the third and fifth decade of life. There is no histological evidence of direct involvement to the central nervous system (CNS); however, it has ben demonstrated the presence of masses and infiltration of the leptomeninges, as well as myasthenia gravis, dysarthria, aphasia, epileptic seizure and coma.
Case report: A 51-year-old male arrived to the emergency room with a two-weeks history of left hemiparesis. The patient was evaluated by the Neurology service, and an angio-MRI showed right internal carotid artery occlusion and multiple infarcts possibly secondary to Castleman disease, associate with right leptomeningitis. The patient was initiated on deflazacort, statins, antiplatelets and physical rehabilitation achieving progressive improvement.
Conclusion: The prognosis of the disease is serious without treatment. The most frequent causes of death in these patients are infections, renal insufficiency and malignancies.


REFERENCES

  1. Miguelez VC, et al. EC mediastínica: presentación de caso. Arch Bronconeumol 2013; 49: 455-456.

  2. Guzmán FM et al. Espectro clínico de la EC Galicia Clin 2014; 75: 191-194.

  3. Sobrevilla CJ, et al. Características clinicopatológicas de la EC. Experiencia en el instituto nacional de cancerología. Cir Ciruj 2009; 77: 187-192.

  4. American Cancer Society. Castleman Disease [Internet]. 1ra ED. American Cancer Society (US). 2014

  5. Bourlon R, et al. EC: reporte de un caso. Med Int Mex 2012; 28: 67-72.

  6. Bonekamp MD, et al. Castleman disease: the great mimic. Radiographics 2011; 31: 1793-1807.

  7. Nolasco DA. EC. Rev Hematol Mex 2014; 15: 21-25.

  8. Garcipérez DF. Et al. EC que infiltra grandes vasos y aurícula derecha. Rev Esp Cardiol 2012; 65: 669-677.

  9. Zapata SA et al. EC Multicentrica tipo hialino vascular en paciente inmunocompetente. Gac Med Mex 2015; 151: 648-654.

  10. Hernández ED, et al. EC multicéntrica asociada a infección por virus de inmunodeficiencia humana reporte del primer caso venezolano. Rev Venez Oncol 2016; 28: 52-55.

  11. Muela MA, et al. EC multicéntrica con afección cerebral reversible. Med Clin (Barc) 2003; 121: 36- 39.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Mex Neuroci. 2016;17